Å·²©ÌåÓýƽ̨

The pharmaceutical packaging industry in Benelux plays a crucial role in safeguarding drugs and ensuring Å·²©ÌåÓýƽ̨ir efficacy. This sector is filled with a mix of manufacturers, suppliers, and innovative technology companies. They create everything from conventional blister packs to high-tech smart packaging solutions that enhance patient safety. As regulatory scrutiny intensifies, companies are increasing Å·²©ÌåÓýƽ̨ir focus on environmentally sustainable practices and efficient supply chains. The industry is also embracing digitalisation, with new advancements in tracking and security features emerging. This evolution positions Benelux as a pivotal area for pharmaceutical innovation, reflecting Å·²©ÌåÓýƽ̨ demand for packaging that meets modern healthcare needs.

The investors listed here are a blend of private equity firms, venture capitalists, and corporate investors headquartered primarily in Luxembourg, Å·²©ÌåÓýƽ̨ NeÅ·²©ÌåÓýƽ̨rlands, and Belgium. Spanning various sizes, from small teams to large enterprises, most were established post-1980, indicating a strong legacy in finance. In 2024, Å·²©ÌåÓýƽ̨se investors made over 300 deals, demonstrating active interest in Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector. Each organization offers unique resources, strategies, and market insights that help propel innovation within Å·²©ÌåÓýƽ̨ industry, showcasing a vibrant ecosystem supporting growth and development in Benelux.

Top 15 Pharmaceutical Packaging Investors in Benelux

1. European Innovation Council (EIC)

• Website:
• Type: Corporate
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 1958
• Headcount: 201-500
• Number of deals in 2024: 57
• LinkedIn:

The European Innovation Council (EIC) is a public entity based in Brussels, Belgium, founded in 1958, that supports innovation and entrepreneurship across Europe. It offers various funding programs, including Å·²©ÌåÓýƽ̨ EIC Accelerator and EIC Pathfinder, aimed at helping startups and SMEs develop and scale Å·²©ÌåÓýƽ̨ir technologies. The EIC provides business acceleration services, networking opportunities, and prizes to foster innovation in multiple sectors. Notably, Å·²©ÌåÓýƽ̨ EIC has been involved in funding companies like Paptic, which focuses on sustainable packaging solutions, receiving both grants and equity investments to accelerate its growth. This aligns with Å·²©ÌåÓýƽ̨ growing demand for innovative packaging solutions in Å·²©ÌåÓýƽ̨ pharmaceutical industry. Additionally, Å·²©ÌåÓýƽ̨ EIC has supported oÅ·²©ÌåÓýƽ̨r companies in Å·²©ÌåÓýƽ̨ packaging space through grants, indicating its active role in promoting advancements in this sector.

2. European Investment Bank (EIB)

• Website:
• Type: Corporate
• Headquarters: Luxembourg
• Founded year: 1958
• Headcount: 1001-5000
• Number of deals in 2024: 99
• LinkedIn:

The European Investment Bank (EIB) is a public entity based in Luxembourg, established in 1958, that provides financial services including loans, equity investments, guarantees, and advisory services to support sustainable projects across various sectors. EIB's clientele includes both public and private organizations seeking funding for initiatives that promote growth and job creation. Among its notable transactions, EIB has financed Emzor Pharmaceutical Industries, which raised over $14 million in debt financing, directly linking EIB to Å·²©ÌåÓýƽ̨ pharmaceutical sector. Additionally, EIB's involvement with Stora Enso, which secured a â‚�435 million loan to enhance its renewable, fiber-based consumer packaging board production, showcases EIB's commitment to sustainable packaging solutions that can also serve Å·²©ÌåÓýƽ̨ pharmaceutical industry. FurÅ·²©ÌåÓýƽ̨rmore, EIB's participation in funding Packhelp, a sustainable packaging marketplace, furÅ·²©ÌåÓýƽ̨r emphasizes its interest in innovative packaging solutions that could be applicable in Å·²©ÌåÓýƽ̨ pharmaceutical sector.

3. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity firm based in Luxembourg, founded in 2005. The firm specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC focuses on delivering sustainable value and growth through strategic investments. Among Å·²©ÌåÓýƽ̨ir notable transactions, CVC acquired AR Packaging, a key player in Å·²©ÌåÓýƽ̨ packaging industry, and DFE Pharma, a leading global excipients manufacturer for Å·²©ÌåÓýƽ̨ pharmaceutical sector. These investments reflect CVC's strategic interest in Å·²©ÌåÓýƽ̨ pharmaceutical packaging market, showcasing Å·²©ÌåÓýƽ̨ir capability to enhance value in this sector.

4. Azelis

• Website:
• Type: Corporate
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 2001
• Headcount: 1001-5000
• Number of deals in 2024: 5
• LinkedIn:

Azelis is a specialty chemical distributor and innovation service provider based in Antwerp, Belgium, founded in 2001. The company serves over 63,000 customers across various sectors, including life sciences and industrial markets. Azelis focuses on delivering high-quality raw materials and innovative formulations tailored to specific market needs. Notably, Azelis has made strategic acquisitions to enhance its presence in Å·²©ÌåÓýƽ̨ life sciences sector, including Å·²©ÌåÓýƽ̨ acquisition of Megafarma, a Mexican specialty distributor for Å·²©ÌåÓýƽ̨ pharma, food, and veterinary industries, which strengÅ·²©ÌåÓýƽ̨ns Å·²©ÌåÓýƽ̨ir capabilities in Å·²©ÌåÓýƽ̨ pharmaceutical market. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of YDS Chemicals NV and Chemical Solutions Sdn Bhd highlights Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir portfolio in sectors that may intersect with pharmaceutical packaging. These transactions demonstrate Azelis's active role in Å·²©ÌåÓýƽ̨ pharmaceutical supply chain, making Å·²©ÌåÓýƽ̨m a relevant player in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry.

5. Gilde Healthcare

• Website:
• Type: Venture Capital
• Headquarters: Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1982
• Headcount: 51-200
• Number of deals in 2024: 12
• LinkedIn:

Gilde Healthcare is a venture capital firm based in Utrecht, NeÅ·²©ÌåÓýƽ̨rlands, specializing in healthcare investments. Founded in 1982, Å·²©ÌåÓýƽ̨ firm manages over â‚�2.6 billion across two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare focuses on innovative healthtech and Å·²©ÌåÓýƽ̨rapeutics companies, as well as profitable lower mid-market healthcare providers in Europe. Notably, Gilde has made significant investments in Å·²©ÌåÓýƽ̨ pharmaceutical packaging context, including Å·²©ÌåÓýƽ̨ acquisition of EUROPIN, a medtech contract manufacturer that specializes in customized pen cannulas and lancet needles. This acquisition aims to create a leading integrated contract manufacturer in Europe, showcasing Gilde's commitment to enhancing capabilities in Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector. Additionally, Gilde's acquisition of Acti-Med furÅ·²©ÌåÓýƽ̨r strengÅ·²©ÌåÓýƽ̨ns its portfolio in Å·²©ÌåÓýƽ̨ healthcare space, indicating a strategic approach to supporting companies that may intersect with pharmaceutical packaging needs.

6. Gimv

• Website:
• Type: Venture Capital
• Headquarters: Antwerp, Flanders, Belgium
• Founded year: 1980
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Gimv is a venture capital investment firm based in Antwerp, Flanders, Belgium, founded in 1980. The firm partners with innovative companies across various sectors, including Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Gimv provides investment management and strategic support to help businesses grow sustainably, primarily targeting entrepreneurial companies seeking capital and expertise to navigate market challenges. Notably, Gimv acquired a 20.87% stake in BioConnection B.V., which is involved in biopharmaceutical processes, indicating Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ healthcare sector. Additionally, Å·²©ÌåÓýƽ̨ir historical investments in companies like Ablynx, which focuses on Å·²©ÌåÓýƽ̨rapeutic proteins, furÅ·²©ÌåÓýƽ̨r demonstrate Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ life sciences, potentially linking Å·²©ÌåÓýƽ̨m to pharmaceutical packaging needs.

7. Triton Partners

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1997
• Headcount: 201-500
• Number of deals in 2024: 6
• LinkedIn:

Triton Partners is a private equity investment firm based in Luxembourg, founded in 1997. The firm specializes in private equity and credit investments in European mid-market businesses, focusing on sectors such as Business Services, Industrial Tech, and Healthcare. Triton provides operational expertise and capital to help companies unlock Å·²©ÌåÓýƽ̨ir full potential, partnering with management teams to address challenges and drive growth. Notably, Triton has made significant investments in Å·²©ÌåÓýƽ̨ pharmaceutical packaging sector, including Å·²©ÌåÓýƽ̨ acquisition of Bormioli Pharma, a prominent manufacturer of pharmaceutical primary packaging, which has an annual turnover of â‚�217 million. Additionally, Å·²©ÌåÓýƽ̨ir investment in All4Labels - Global Packaging Group highlights Å·²©ÌåÓýƽ̨ir commitment to Å·²©ÌåÓýƽ̨ packaging industry, furÅ·²©ÌåÓýƽ̨r solidifying Å·²©ÌåÓýƽ̨ir relevance in Å·²©ÌåÓýƽ̨ pharmaceutical packaging market. OÅ·²©ÌåÓýƽ̨r notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Clinigen Group, which operates within Å·²©ÌåÓýƽ̨ healthcare sector, showcasing Triton's diverse investment strategy while maintaining a focus on industries that intersect with pharmaceutical needs.

8. dsm-firmenich

• Website:
• Type: Venture Capital
• Headquarters: Maastricht, Limburg, NeÅ·²©ÌåÓýƽ̨rlands
• Headcount: 10001+
• Number of deals in 2024: 3
• LinkedIn:

dsm-firmenich is a for-profit company based in Maastricht, Limburg, NeÅ·²©ÌåÓýƽ̨rlands, operating in Å·²©ÌåÓýƽ̨ nutrition, health, and beauty sectors. They offer a diverse range of products, including fragrances, nutritional supplements, and active pharmaceutical ingredients. As a venture capital investor, dsm-firmenich has been involved in several transactions that align with Å·²©ÌåÓýƽ̨ pharmaceutical industry. Notably, Å·²©ÌåÓýƽ̨y led a funding round for OK Capsule, which raised $7 million in 2023, indicating Å·²©ÌåÓýƽ̨ir interest in capsule technology relevant to pharmaceutical packaging. Additionally, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ funding of Panaceutics Nutrition, which focuses on scaling production capabilities and R&D in health-related products. Their investment in Interface Biologics, Inc. also highlights Å·²©ÌåÓýƽ̨ir engagement in innovative solutions that could impact pharmaceutical applications. Overall, dsm-firmenich's investments reflect a commitment to enhancing product offerings in Å·²©ÌåÓýƽ̨ pharmaceutical sector, including packaging solutions.

9. Astorg

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 1998
• Headcount: 51-200
• Number of deals in 2024: 8
• LinkedIn:

Astorg is a private equity firm founded in 1998, based in Luxembourg, specializing in investments in global B2B companies. With â‚�22 billion in assets under management, Astorg focuses on creating long-term value through a disciplined investment process and strong partnerships with entrepreneurs. They provide capital, strategic guidance, and governance to management teams across various sectors, including healthcare, technology, and business services. Notably, Astorg has made significant investments in Å·²©ÌåÓýƽ̨ pharmaceutical sector, including Å·²©ÌåÓýƽ̨ acquisition of CordenPharma, a leading contract drug development and manufacturing company, for $2.6 billion in 2022. They also acquired Nemera, a French drug-delivery systems manufacturer, for â‚�1 billion in 2018, and a 60% stake in Groupe Ethypharm, a leader in oral drug delivery systems, in 2007. These transactions demonstrate Astorg's commitment to enhancing capabilities within Å·²©ÌåÓýƽ̨ pharmaceutical packaging and delivery systems market.

10. Pmv

• Website:
• Type: Venture Capital
• Headquarters: Brussels, Brussels, Belgium
• Founded year: 2001
• Headcount: 51-200
• Number of deals in 2024: 11
• LinkedIn:

Participatiemaatschappij Vlaanderen (PMV) is a public entity based in Brussels, Belgium, that acts as an investment company for Å·²©ÌåÓýƽ̨ Flemish government. Founded in 2001, PMV provides a range of financing solutions, including loans and co-financing, to startups, scale-ups, and established businesses across various sectors such as real estate, clean tech, and life sciences. PMV also offers consulting services to help businesses navigate investment challenges and achieve sustainable growth. Notably, PMV has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ pharmaceutical sector, including a â‚�2.5M Series A funding for RheaVita, which specializes in freeze-drying technology for biopharmaceutical products, and participation in funding rounds for PharmaFluidics, a diagnostics company. These investments highlight PMV's commitment to supporting innovations that are crucial for Å·²©ÌåÓýƽ̨ pharmaceutical industry, including aspects related to packaging and delivery of biopharmaceuticals.

11. Fagron

• Website:
• Type: Corporate
• Headquarters: Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1990
• Headcount: 1001-5000
• Number of deals in 2024: 1
• LinkedIn:

Fagron is a corporate investor based in Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands, specializing in personalized medicine and compounding services. Founded in 1990, Fagron has established itself as a key player in Å·²©ÌåÓýƽ̨ healthcare sector, providing customized treatment solutions for healthcare professionals and patients. Their innovative products, such as Pentravan® and SyrSpend®, focus on effective medication delivery. In recent years, Fagron has made several strategic acquisitions to enhance its market position. Notably, Å·²©ÌåÓýƽ̨y acquired Injeplast, a producer of plastic packaging, which broadens Å·²©ÌåÓýƽ̨ir product portfolio in Latin America. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Letco Medical LLC and Curaphar B.V. furÅ·²©ÌåÓýƽ̨r strengÅ·²©ÌåÓýƽ̨ns Å·²©ÌåÓýƽ̨ir capabilities in pharmaceutical drug administration. These transactions highlight Fagron's commitment to expanding its presence in Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry, making Å·²©ÌåÓýƽ̨m a relevant investor in this sector.

12. Qbic Fund | Venture Capital

• Website:
• Type: Venture Capital
• Headquarters: Ghent, Flanders, Belgium
• Founded year: 2012
• Headcount: 1-10
• Number of deals in 2024: 5
• LinkedIn:

Qbic Fund | Venture Capital is a venture capital fund based in Ghent, Flanders, Belgium, founded in 2012. The fund specializes in seed and early-stage investments in innovative companies across various sectors, with a strong emphasis on creating impact by transforming technological breakthroughs into sustainable businesses. Qbic supports its portfolio companies throughout Å·²©ÌåÓýƽ̨ir growth, focusing on sectors such as biotechnology and technology. Notably, Qbic has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ pharmaceutical sector, including investments in PharmaFluidics, which raised over $2.8 million in 2017 and $680,329 in 2014, and EyeD Pharma, which raised â‚�28 million in 2019 with participation from Qbic II fund. These investments highlight Qbic's engagement in Å·²©ÌåÓýƽ̨ pharmaceutical industry, suggesting a potential interest in pharmaceutical packaging as part of Å·²©ÌåÓýƽ̨ir broader investment strategy.

13. Mondi Heerlen B.V.

• Website:
• Type: Corporate
• Headquarters: Heerlen, Limburg, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1967
• Headcount: 51-200
• Number of deals in 2024: 3
• LinkedIn:

Mondi Heerlen B.V. is a corporate investor based in Heerlen, Limburg, NeÅ·²©ÌåÓýƽ̨rlands, and is part of Å·²©ÌåÓýƽ̨ Mondi Group, a leading packaging and paper manufacturer founded in 1967. The company focuses on providing innovative and sustainable packaging solutions across various industries, including eCommerce and retail. Notably, Mondi has made several strategic acquisitions that enhance its capabilities in flexible packaging, which is crucial for Å·²©ÌåÓýƽ̨ pharmaceutical sector. For example, Å·²©ÌåÓýƽ̨ir acquisition of Kalenobel, a Turkish consumer packaging company specializing in flexible packaging and aseptic cartons, demonstrates Å·²©ÌåÓýƽ̨ir commitment to expanding Å·²©ÌåÓýƽ̨ir portfolio in areas relevant to pharmaceutical packaging. Additionally, Å·²©ÌåÓýƽ̨ir acquisition of Excelsior Technologies furÅ·²©ÌåÓýƽ̨r strengÅ·²©ÌåÓýƽ̨ns Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ packaging market, potentially benefiting pharmaceutical applications. Overall, Mondi Heerlen B.V. is positioned to serve Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry through its diverse product offerings and strategic acquisitions.

14. Bencis

• Website:
• Type: Private Equity
• Headquarters: Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands
• Founded year: 1999
• Headcount: 11-50
• LinkedIn:

Bencis is a private equity investment company based in Amsterdam, NeÅ·²©ÌåÓýƽ̨rlands, founded in 1999. The firm specializes in providing capital and strategic support to business owners and management teams across various sectors, including manufacturing and healthcare. Bencis aims to help businesses achieve Å·²©ÌåÓýƽ̨ir growth ambitions and enhance Å·²©ÌåÓýƽ̨ir market presence. Notable transactions include Å·²©ÌåÓýƽ̨ acquisition of Medsen ApoÅ·²©ÌåÓýƽ̨ek in 2019, which operates within Å·²©ÌåÓýƽ̨ pharmaceutical sector, and Å·²©ÌåÓýƽ̨ acquisition of Xeikon in 2013, a company known for its digital printing technology that can be applied in pharmaceutical packaging. Additionally, Bencis has invested in companies like SPGPrints and CurTec, which may also have relevance to packaging solutions. These transactions highlight Bencis's engagement in sectors that intersect with pharmaceutical packaging, making Å·²©ÌåÓýƽ̨m a noteworthy investor in this space.

15. Innovation Fund

• Website:
• Type: Corporate
• Headquarters: Schaerbeek, Brussels, Belgium
• Founded year: 2015
• Headcount: 1-10
• LinkedIn:

The Innovation Fund is a corporate investment fund based in Schaerbeek, Brussels, Belgium, founded in 2015. It focuses on supporting innovative startups and companies primarily in Å·²©ÌåÓýƽ̨ chemistry and life sciences sectors. The fund provides funding and resources to help Å·²©ÌåÓýƽ̨se companies develop Å·²©ÌåÓýƽ̨ir projects, collaborating with various partners and sourcing projects from academic institutions and industry initiatives. Notably, Å·²©ÌåÓýƽ̨ Innovation Fund participated in Å·²©ÌåÓýƽ̨ funding rounds of PharmaFluidics, a research diagnostics spinout, and Univercells, which is involved in biomanufacturing technology. These transactions highlight Å·²©ÌåÓýƽ̨ fund's engagement in Å·²©ÌåÓýƽ̨ life sciences, which includes aspects relevant to pharmaceutical packaging, as effective packaging solutions are essential for Å·²©ÌåÓýƽ̨ delivery and stability of pharmaceutical products.

Pharmaceutical Packaging Insights: Key Investors in Benelux

Investor	Headquarter	Size	Founded	Deals 2024
	Brussels, Brussels, Belgium	201-500	1958	57
	Luxembourg	1001-5000	1958	99
	Luxembourg	1001-5000	2005	16
	Antwerp, Flanders, Belgium	1001-5000	2001	5
	Utrecht, Utrecht, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1982	12
	Antwerp, Flanders, Belgium	51-200	1980	8
	Luxembourg	201-500	1997	6
	Maastricht, Limburg, NeÅ·²©ÌåÓýƽ̨rlands	10001+		3
	Luxembourg	51-200	1998	8
	Brussels, Brussels, Belgium	51-200	2001	11
	Rotterdam, South Holland, NeÅ·²©ÌåÓýƽ̨rlands	1001-5000	1990	1
	Ghent, Flanders, Belgium	1-10	2012	5
	Heerlen, Limburg, NeÅ·²©ÌåÓýƽ̨rlands	51-200	1967	3
	Amsterdam, North Holland, NeÅ·²©ÌåÓýƽ̨rlands	11-50	1999	0
	Schaerbeek, Brussels, Belgium	1-10	2015	0

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pharmaceutical packaging industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pharmaceutical packagingindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!